International journal of molecular sciences

Anti-Aging Effects of Drugs That Change Metabolism: Pharmacology Perspectives

Updated

Abstract

Pharmacological modulation of molecular pathways may extend healthspan and delay multimorbidity.

  • Aging is linked to increased risk for chronic diseases like cardiovascular diseases and cancer.
  • Repurposed drugs such as metformin and rapamycin show extensive preclinical evidence for potential geroprotection, but clinical applicability remains limited.
  • Other drugs like statins and GLP-1 receptor agonists have disease-specific benefits, yet their direct impact on biological aging is unproven.
  • Emerging candidates, including senolytics and NAD+ precursors, are at various stages of development, with some early human studies showing promise.
  • There is a significant gap between theoretical mechanisms and validated clinical outcomes in geroprotective pharmacology.
  • Major uncertainties include the lack of accepted biomarkers for biological aging and the variability in treatment responses.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free